Evidence map›Paper›PMID 25721933›Full record

ArticleNature communications2015

Semaphorin7A regulates neuroglial plasticity in the adult hypothalamic median eminence.

Jyoti Parkash, Andrea Messina, Fanny Langlet, Irene Cimino, Anne Loyens, Danièle Mazur, Sarah Gallet, Eglantine Balland, Samuel A Malone, François Pralong and 8 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 137 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. GnRH and Cognition.Endocrinology · 2025
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Pan-Cancer Analysis of the Prognostic and Immunological Role of SEMA7A.International journal of general medicine · 2024
    Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 4 countries.

Jyoti Parkash1] Inserm, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Jean-Pierre Aubert Research Centre, U1172, 59045 Lille, France [2] University of Lille, School of Medicine and Institut de Medecine Predictive et de Recherche Therapeutique (IMPRT-IFR114), 59045 Lille, France.
Andrea Messina1] Inserm, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Jean-Pierre Aubert Research Centre, U1172, 59045 Lille, France [2] University of Lille, School of Medicine and Institut de Medecine Predictive et de Recherche Therapeutique (IMPRT-IFR114), 59045 Lille, France.
Fanny Langlet1] Inserm, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Jean-Pierre Aubert Research Centre, U1172, 59045 Lille, France [2] University of Lille, School of Medicine and Institut de Medecine Predictive et de Recherche Therapeutique (IMPRT-IFR114), 59045 Lille, France.
Irene Cimino1] Inserm, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Jean-Pierre Aubert Research Centre, U1172, 59045 Lille, France [2] University of Lille, School of Medicine and Institut de Medecine Predictive et de Recherche Therapeutique (IMPRT-IFR114), 59045 Lille, France.
Anne Loyens1] Inserm, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Jean-Pierre Aubert Research Centre, U1172, 59045 Lille, France [2] University of Lille, School of Medicine and Institut de Medecine Predictive et de Recherche Therapeutique (IMPRT-IFR114), 59045 Lille, France.
Danièle Mazur1] Inserm, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Jean-Pierre Aubert Research Centre, U1172, 59045 Lille, France [2] University of Lille, School of Medicine and Institut de Medecine Predictive et de Recherche Therapeutique (IMPRT-IFR114), 59045 Lille, France.
Sarah Gallet1] Inserm, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Jean-Pierre Aubert Research Centre, U1172, 59045 Lille, France [2] University of Lille, School of Medicine and Institut de Medecine Predictive et de Recherche Therapeutique (IMPRT-IFR114), 59045 Lille, France.
Eglantine Balland1] Inserm, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Jean-Pierre Aubert Research Centre, U1172, 59045 Lille, France [2] University of Lille, School of Medicine and Institut de Medecine Predictive et de Recherche Therapeutique (IMPRT-IFR114), 59045 Lille, France.
Samuel A Malone1] Inserm, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Jean-Pierre Aubert Research Centre, U1172, 59045 Lille, France [2] University of Lille, School of Medicine and Institut de Medecine Predictive et de Recherche Therapeutique (IMPRT-IFR114), 59045 Lille, France.
François PralongService of Endocrinology, Diabetology and Metabolism, Faculty of Biology and Medicine, University Hospital, 1011 Lausanne, Switzerland.
Gabriella Cagnoni1] Candiolo Cancer Institute-FPO, IRCCS, 10060 Candiolo, Italy [2] Department of Oncology, University of Torino, 10060 Candiolo, Italy.
Roberta SchellinoDipartimento di Scienze della Vita e Biologia dei Sistemi, University of Torino, 10100 Torino, Italy.
Silvia De MarchisDipartimento di Scienze della Vita e Biologia dei Sistemi, University of Torino, 10100 Torino, Italy.
Massimiliano Mazzone1] Laboratory of Molecular Oncology and Angiogenesis, Vesalius Research Center, VIB, B-3000 Leuven, Belgium [2] Laboratory of Molecular Oncology and Angiogenesis, Vesalius Research Center, Department of Oncology, KU Leuven, B-3000 Leuven, Belgium.
R Jeroen PasterkampDepartment of Translational Neuroscience, Brain Center Rudolf Magnus, University Medical Center Utrecht, 3584 CG11 Utrecht, The Netherlands.
Luca Tamagnone1] Candiolo Cancer Institute-FPO, IRCCS, 10060 Candiolo, Italy [2] Department of Oncology, University of Torino, 10060 Candiolo, Italy.
Vincent Prevot1] Inserm, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Jean-Pierre Aubert Research Centre, U1172, 59045 Lille, France [2] University of Lille, School of Medicine and Institut de Medecine Predictive et de Recherche Therapeutique (IMPRT-IFR114), 59045 Lille, France.
Paolo Giacobini1] Inserm, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Jean-Pierre Aubert Research Centre, U1172, 59045 Lille, France [2] University of Lille, School of Medicine and Institut de Medecine Predictive et de Recherche Therapeutique (IMPRT-IFR114), 59045 Lille, France.
Inserm · FRUniversité de Lille · FRUniversity of Turin · ITCandiolo Cancer Institute · ITCentre de Recherche Jean Pierre Aubert · FRIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversity Medical Center Utrecht · NLVIB-KU Leuven Center for Cancer Biology · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reproductive competence in mammals depends on the projection of gonadotropin-releasing hormone (GnRH) neurons to the hypothalamic median eminence (ME) and the timely release of GnRH into the hypothalamic-pituitary-gonadal axis. In adult rodents, GnRH neurons and the specialized glial cells named tanycytes periodically undergo cytoskeletal plasticity. However, the mechanisms that regulate this plasticity are still largely unknown. We demonstrate that Semaphorin7A, expressed by tanycytes, plays a dual role, inducing the retraction of GnRH terminals and promoting their ensheathment by tanycytic end feet via the receptors PlexinC1 and Itgb1, respectively. Moreover, Semaphorin7A expression is regulated during the oestrous cycle by the fluctuating levels of gonadal steroids. Genetic invalidation of Semaphorin7A receptors in mice induces neuronal and glial rearrangements in the ME and abolishes normal oestrous cyclicity and fertility. These results show a role for Semaphorin7A signalling in mediating periodic neuroglial remodelling in the adult ME during the ovarian cycle.

Indexed as

Analysis of VarianceAnimalsAntigens, CDBlotting, WesternEnzyme-Linked Immunosorbent AssayEstradiolFemaleFlow CytometryFluorescent Antibody TechniqueImage Processing, Computer-AssistedImmunohistochemistryMedian EminenceMiceNeurogliaNeuronal PlasticityOvariectomyAntigens, CDEstradiolestradiol 3-benzoateProgesteroneSema7a protein, ratSemaphorins

Identifiers

PMID25721933
PMCPMC4351556
OpenAlexW2075141289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.